Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anticancer Treatment”

142 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 142 results

Not applicableLooking for participantsNCT06680401
What this trial is testing

Epithelioid Haemangioendothelioma Observational Study

Who this might be right for
Clinical PresentationNatural HistoryTreatment Outcomes
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 50
Not applicableLooking for participantsNCT04484064
What this trial is testing

Optimization of the Targeted Anticancer Therapies

Who this might be right for
Cancer
Centre Hospitalier Universitaire Vaudois 500
Early research (Phase 1)UnknownNCT03903458
What this trial is testing

Tinostamustine and Nivolumab in Advanced Melanoma

Who this might be right for
Malignant Melanoma
Markus Joerger 21
Testing effectiveness (Phase 2)Looking for participantsNCT05525247
What this trial is testing

A Phase 1/2, Open-label, Multicenter, Dose Escalation and Expansion Study of SLC-3010 Monotherapy and in Combination

Who this might be right for
Advanced Solid Tumor
Selecxine 420
Not applicableStudy completedNCT06161181
What this trial is testing

Enhancing Therapy Adherence Among Metastatic Breast Cancer Patients

Who this might be right for
Metastatic Breast Cancer
European Institute of Oncology 94
Testing effectiveness (Phase 2)Looking for participantsNCT06923761
What this trial is testing

EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1)

Who this might be right for
Advanced Solid Malignancy
Grey Wolf Therapeutics 300
Not applicableStudy completedNCT05350930
What this trial is testing

Multidisciplinary Care Program to Secure MEdication Therapy for HematoLOgy Patients Receiving Injectable Anticancer Drugs

Who this might be right for
Chemotherapy EffectG-CHOP ChemotherapyR-CHOP Chemotherapy
Hospices Civils de Lyon 38
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Not applicableLooking for participantsNCT06713993
What this trial is testing

Semmelweis Esophageal Cancer Study: Noninvasive Prognostic Parameters in Patients With Oesophageal and Esophagogastric Junction Cancer

Who this might be right for
Esophageal Cancer (EsC)
Semmelweis University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05081609
What this trial is testing

Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
Advanced Solid TumorLocally Advanced Solid TumorMetastatic Solid Tumor+10 more
Ascendis Pharma Oncology Division A/S 320
Not applicableStudy completedNCT03952312
What this trial is testing

Oncotool for Cancer Medications

Who this might be right for
CancerCancer, Treatment-RelatedMedication Adherence+2 more
Northwestern University 83
Not applicableUnknownNCT02733965
What this trial is testing

Impact of Clinical Pharmacy Consultations in Patients With Cancer Treated With Oral Anti-cancer Therapies on the Rate of Serious Adverse Events

Who this might be right for
Oral Anticancer Therapy.
Assistance Publique Hopitaux De Marseille 190
Not applicableLooking for participantsNCT06317714
What this trial is testing

Long-term Follow-up and Quality of Life of Patients Treated With Anticancer Drugs

Who this might be right for
OncologyQuality of LifeSymptoms and Signs
Institut Rafael 300
Testing effectiveness (Phase 2)Study completedNCT02818426
What this trial is testing

Universal Cancer Peptide-based Vaccination in Metastatic NSCLC

Who this might be right for
Metastatic Non-small Cell Lung Cancer
Centre Hospitalier Universitaire de Besancon 82
Large-scale testing (Phase 3)Study completedNCT00003884
What this trial is testing

Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone

Who this might be right for
Hypercalcemia of MalignancyLung CancerMetastatic Cancer+2 more
Novartis 600
Testing effectiveness (Phase 2)Looking for participantsNCT07241767
What this trial is testing

A Phase II Clinical Study of FH-006 for Injection Combined With Other Anticancer Therapies in Subjects With Lung Cancer

Who this might be right for
Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 200
Early research (Phase 1)Active Not RecruitingNCT04722146
What this trial is testing

Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 140
Testing effectiveness (Phase 2)Active Not RecruitingNCT05548127
What this trial is testing

TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)

Who this might be right for
Breast Cancer
Pfizer 37
Not applicableStudy completedNCT02216604
What this trial is testing

Exercise in Pediatric Cancer Patient Undergoing Anti-Cancer Treatment

Who this might be right for
Childhood Cancer
German Cancer Research Center 50
Early research (Phase 1)Study completedNCT01447225
What this trial is testing

Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Merrimack Pharmaceuticals 43
Load More Results